MYLAN PHARMS INC FDA Approval ANDA 086445

ANDA 086445

MYLAN PHARMS INC

FDA Drug Application

Application #086445

Application Sponsors

ANDA 086445MYLAN PHARMS INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL500MG0TOLBUTAMIDETOLBUTAMIDE

FDA Submissions

ORIG1AP1979-04-10
MANUF (CMC); Manufacturing (CMC)SUPPL43AP1982-03-18
MANUF (CMC); Manufacturing (CMC)SUPPL45AP1984-09-18
MANUF (CMC); Manufacturing (CMC)SUPPL51AP1987-08-28
LABELING; LabelingSUPPL52AP1989-08-08
MANUF (CMC); Manufacturing (CMC)SUPPL53AP1990-01-31
LABELING; LabelingSUPPL54AP1991-01-23
MANUF (CMC); Manufacturing (CMC)SUPPL56AP1993-11-03
MANUF (CMC); Manufacturing (CMC)SUPPL57AP1998-02-25
MANUF (CMC); Manufacturing (CMC)SUPPL58AP1998-02-05
LABELING; LabelingSUPPL59AP2001-09-27
LABELING; LabelingSUPPL63AP2009-11-12

Submissions Property Types

SUPPL43Null0
SUPPL45Null0
SUPPL51Null0
SUPPL53Null0
SUPPL56Null0
SUPPL57Null0
SUPPL58Null0
SUPPL63Null7

CDER Filings

MYLAN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 86445
            [companyName] => MYLAN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TOLBUTAMIDE","activeIngredients":"TOLBUTAMIDE","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TOLBUTAMIDE","submission":"TOLBUTAMIDE","actionType":"500MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.